comprehensive -WSS

comprehensive

author：entertainment 2025-10-01 18:33:31 - browse：58888

Pfizer and Moderna aren’t the only vaccine money-makers. Much of the revenue and profits from Covid-19 vaccines are flowing behind the scenes, going to the contract manufacturers and clinical-trial organizers that turn the shots from lab-bench theory to mass-produced reality.

Both AstraZeneca and Johnson & Johnson publicly committed to not profiting off their products during the pandemic — though AstraZeneca has reserved the right to declare the pandemic over on July 1, even if the World Health Organization has not. Pfizer and Moderna made no such pledge, with Pfizer expected to make $15 billion in vaccine-related revenue this year, while Moderna is forecasting $18.4 billion in vaccine sales.

Contractors hired to test and manufacture these vaccines have enjoyed a share of the profits without the same level of public scrutiny.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： 'CMA Fest' 2023: How to watch, who is performing and more

hotspot

knowledge

WSS

When a patient nears the end, a feared therapy can comfort

Steward Health Care expansion into Malta flopped

Steward Health Care expansion into Malta flopped

What Kate Middleton's cancer revelation might teach the world

'Patient friction coefficient' can gauge a clinical trial's patient burden

When a patient nears the end, a feared therapy can comfort

knowledge

comprehensive

hotspot

Supreme Court strikes down use of affirmative action

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Psychedelics group wrestles with new pharma identity

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Peter Hotez and the public health issue of online harassment

Chinese researcher claims birth of first gene

How one medical school became remarkably diverse

US jobless claims fall again as labor market continues to flash strength

Jerome Adams on the need for new antivirals for Covid

'Patient friction coefficient' can gauge a clinical trial's patient burden

hotspot

After a decade, new Gardasil ad campaign gets it (mostly) right

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

In rare move, senator releases unverified FBI source report alleging Biden bribe

Biotech investment managers search for lucrative opportunities

With Wegovy coverage, Medicare patients may face high costs

Testing GLP

hotspot

knowledge

Wikipedia

leisure time